Truist Raises Hinge Health Price Target to $145, Keeps Buy Rating
Truist raised its price target on Hinge Health to $145 from $112 and maintained a Buy rating.
Truist raised its price target on Hinge Health to $145 from $112 and maintained a Buy rating.